American Society of Clinical Oncology

Latest articles

19m
Newsweek
How new cancer clinical trials search tools make it easier for patients to find the treatment they needa lung cancer drug. In June 2012, his colleagues presented their Phase I clinic
Newsweek / Posted 19 minutes ago
a lung cancer drug. In June 2012, his colleagues presented their Phase I clinical trial data at the Annual Meeting of the American Society of Clinical Oncology. “It really had felt like we struck a blow to cancer,” Marsilje says. Six hours later,... Read more
4h
Orlando Sentinel
5 questions about the brain cancer diagnosed in Sen. John McCainthan women, are diagnosed with various types of primary brain cancers a year, a
Orlando Sentinel / Posted 4 hours ago
than women, are diagnosed with various types of primary brain cancers a year, according to Cancer.net, a web site of the American Society of Clinical Oncology. Unlike most other cancers, brain tumors do not spread to other parts of the body. They... Read more
552 related articles
9h
Your Hometown Lima Stations
Nuts! Good medicine for colon cancer survivors?than those with the lowest scores. Both studies are scheduled for presentation
Your Hometown Lima Stations / Posted 9 hours ago
than those with the lowest scores. Both studies are scheduled for presentation next month at the annual meeting of the American Society of Clinical Oncology (ASCO), in Chicago. "Diet and lifestyle can influence both the risk of cancer coming... Read more
10h
Baltimore Sun
5 questions about the brain cancer diagnosed in Sen. John McCainthan women, are diagnosed with various types of primary brain cancers a year, a
Baltimore Sun / Posted 10 hours ago
than women, are diagnosed with various types of primary brain cancers a year, according to Cancer.net, a web site of the American Society of Clinical Oncology. Unlike most other cancers, brain tumors do not spread to other parts of the body. They... Read more
552 related articles
10h
Chicago Tribune
5 questions about the brain cancer diagnosed in Sen. John McCainthan women, are diagnosed with various types of primary brain cancers a year, a
Chicago Tribune / Posted 10 hours ago
than women, are diagnosed with various types of primary brain cancers a year, according to Cancer.net, a web site of the American Society of Clinical Oncology. Unlike most other cancers, brain tumors do not spread to other parts of the body. They... Read more
552 related articles
11h
San Antonio Express-News
5 questions about the brain cancer diagnosed in McCainthan women, are diagnosed with various types of primary brain cancers a year, a
San Antonio Express-News / Posted 11 hours ago
than women, are diagnosed with various types of primary brain cancers a year, according to Cancer.net, a web site of the American Society of Clinical Oncology. Unlike most other cancers, brain tumors do not spread to other parts of the body. They... Read more
552 related articles
1d
PR.com
Arteric President and Co-Founder Hans Kaspersetz Leads Workshops to Enhance Digital Marketing Capacity of Cancer-Related Advocacy Organizationstactics, such as augmented reality and artificial intelligence. The program coi
PR.com / Posted yesterday
tactics, such as augmented reality and artificial intelligence. The program coincided with the 2017 annual meeting of the American Society of Clinical Oncology (ASCO). Along with teaching best practices and leading-edge digital strategy and... Read more
3d
Digi Times
Taipei Medical University introduces IBM Watson for Oncologythan 15 million pages of reports to provide relevant information and insight fo
Digi Times / Posted 3 days ago
than 15 million pages of reports to provide relevant information and insight for IBM Watson for Oncology to keep learning. American Society of Clinical Oncology (ASCO) had studied IBM Watson for Oncology and in 2014 found that it could agree with... Read more
3d
Scoop.co.nz
NZ 2nd in the world to register KEYTRUDA - chemo combinationor without pembrolizumab for advanced nonsquamous NSCLC: Updated Results for KE
Scoop.co.nz / Posted 3 days ago
or without pembrolizumab for advanced nonsquamous NSCLC: Updated Results for KEYNOTE-021 Cohort G. Poster presented at the American Society of Clinical Oncology (ASCO) Annual Meeting. June 2-6, 2017, Chicago. IL, USA 5. Langer et al, Carboplatin... Read more
7d
San Antonio Express-News
Breast cancer drug by AstraZeneca slows inherited diseaseless likely to see their cancer spread than those given conventional chemothera
San Antonio Express-News / Posted 7 days ago
less likely to see their cancer spread than those given conventional chemotherapy, according to results presented at the American Society of Clinical Oncology meeting, which ran through Tuesday in Chicago. Women taking Lynparza had their disease... Read more
7d
Business Wire
Nanobiotix Revenues for the 2nd Quarter of 2017presented the results of the Phase I/II head and neck cancer trial with its lea
Business Wire / Posted 7 days ago
presented the results of the Phase I/II head and neck cancer trial with its lead product candidate, NBTXR3, at the American Society of Clinical Oncology (ASCO), Chicago in June. The excellent safety profile demonstrated in this elderly and... Read more
7d
Market Watch
Technical trading: These four stocks are breaking out of their patternare topping our charts today. Bluebird bio Inc.BLUE, +0.26% has been on a wond
Market Watch / Posted 7 days ago
are topping our charts today. Bluebird bio Inc.BLUE, +0.26% has been on a wonderful run following its presentation at the American Society of Clinical Oncology (ASCO) meeting June 5. Although it pulled back this past Monday, it snapped right back... Read more
13d
MedCity News
Nanobiotix leverages physics to fight cancerof the biology.” Early phase trial results in head and neck cancers have been
MedCity News / Posted 13 days ago
of the biology.” Early phase trial results in head and neck cancers have been encouraging. A study released at the recent American Society of Clinical Oncology (ASCO) meeting showed the treatment performed well in older patients with stage III and... Read more
14d
FOX Business
How a Conference Caused Bluebird Bio's Shares to Rocket 33% in Juneare working on therapies that reengineer a patient's T-cells so that they can s
FOX Business / Posted 14 days ago
are working on therapies that reengineer a patient's T-cells so that they can spot and destroy cancer cells. At the annual American Society of Clinical Oncology conference last month, bluebird bio said that its bb2121, a treatment it's developing... Read more
14d
FOX Business
How a Conference Caused Bluebird Bio's Shares to Rocket 33% in Juneare working on therapies that reengineer a patient's T-cells so that they can s
FOX Business / Posted 14 days ago
are working on therapies that reengineer a patient's T-cells so that they can spot and destroy cancer cells. At the annual American Society of Clinical Oncology conference last month, bluebird bio said that its bb2121, a treatment it's developing... Read more
16d
Business Wire
Commercial Interests at ASCO 2017 - A 1st Oncology Insights ReportASCO 2017 report is a must have companion tool for reviewing the direction of c
Business Wire / Posted 16 days ago
ASCO 2017 report is a must have companion tool for reviewing the direction of commercial drug development emerging from the American Society of Clinical Oncology (ASCO) Annual Meeting 2017. Break through the mountain of close 5,000 abstracts... Read more
16d
Decclan Chronicle
Pregnancy doesn’t pose threat of cancer recurrence: Doctorsto the question seems to have come in the form of a study whose results were re
Decclan Chronicle / Posted 16 days ago
to the question seems to have come in the form of a study whose results were released recently. The study conducted at American Society of Clinical Oncology on breast cancer survivors presented no difference in recurrence rates if women... Read more
17d
Daytona Beach News-Journal
Hope vs. Hype: Widespread hype gives false hope to many cancer patientsto two years. Forty percent of patients were alive three years later, according
Daytona Beach News-Journal / Posted 17 days ago
to two years. Forty percent of patients were alive three years later, according to the clinical trial, presented at the American Society of Clinical Oncology. Researchers have tested immunotherapies against a variety of tumors, leading to... Read more
21d
Business Wire
Chi-Med and AstraZeneca Initiate SAVOIR, a Global Phase III Trial of Savolitinib in Papillary Renal Cell Carcinomain PRCC In February 2017, the results of a global Phase II multicenter study i
Business Wire / Posted 21 days ago
in PRCC In February 2017, the results of a global Phase II multicenter study in advanced PRCC was presented at the 2017 American Society of Clinical Oncology Genitourinary Cancers Symposium, which indicated a clear efficacy signal with... Read more
22d
Business Wire
Update van data van Fase IIIb MAGNIFY studie van REVLIMID (lenalidomide) en rituximab combinatie (R2) tonen klinische activiteit en reacties bij recidiverende / refractair folliculair lymfoom en randzoneZwitserland. De resultaten zijn uitgebreid met data die eerder deze maand zijn
Business Wire / Posted 22 days ago
Zwitserland. De resultaten zijn uitgebreid met data die eerder deze maand zijn gepresenteerd op de vergadering van de American Society of Clinical Oncology (ASCO) in Chicago in de Amerikaanse staat Illinois. Deze bekendmaking is officieel... Read more
76 related articles
24d
FOX Business
5 Best Biotech Stocks of 2017 So Farof the stock. Perhaps the best news for the biotech was its announcement in May
FOX Business / Posted 24 days ago
of the stock. Perhaps the best news for the biotech was its announcement in May of encouraging data to be presented at the American Society of Clinical Oncology (ASCO) for mirvetuximab soravtansine in treating ovarian cancer.Sangamo... Read more
24d
FOX Business
5 Best Biotech Stocks of 2017 So Farof the stock. Perhaps the best news for the biotech was its announcement in May
FOX Business / Posted 24 days ago
of the stock. Perhaps the best news for the biotech was its announcement in May of encouraging data to be presented at the American Society of Clinical Oncology (ASCO) for mirvetuximab soravtansine in treating ovarian cancer.Sangamo... Read more
24d
FOX Business
3 Reasons to Buy Celgene Stock and Never Selland Bluebird have worked together since 2013. The partners recently reported so
FOX Business / Posted 24 days ago
and Bluebird have worked together since 2013. The partners recently reported some very encouraging data on bb2121 at the American Society of Clinical Oncology (ASCO) meeting. However, Celgene also has partnered with some large companies, such as... Read more
24d
FOX Business
3 Reasons to Buy Celgene Stock and Never Selland Bluebird have worked together since 2013. The partners recently reported so
FOX Business / Posted 24 days ago
and Bluebird have worked together since 2013. The partners recently reported some very encouraging data on bb2121 at the American Society of Clinical Oncology (ASCO) meeting. However, Celgene also has partnered with some large companies, such as... Read more
28d
Inquirier.net
Fil-Am nurse cares for ‘the other cancer patient’ – the caregiverChiba University, Japan. He often travels to the Philippines and will return to
Inquirier.net / Posted 28 days ago
Chiba University, Japan. He often travels to the Philippines and will return to Manila in October with physicians from the American Society of Clinical Oncology and another nurse from the Oncology Nursing Society to share their expertise with... Read more
28d
WIS News 10 Columbia
Many doctors silent on cost of cancer caresupport to facilitate action in response to recognized financial toxicity." Th
WIS News 10 Columbia / Posted 28 days ago
support to facilitate action in response to recognized financial toxicity." The findings were presented recently at the American Society of Clinical Oncology annual meeting in Chicago. The results should be considered preliminary until published... Read more
6 related articles
28d
WLBT 3 Jackson
Many doctors silent on cost of cancer caresupport to facilitate action in response to recognized financial toxicity." Th
WLBT 3 Jackson / Posted 28 days ago
support to facilitate action in response to recognized financial toxicity." The findings were presented recently at the American Society of Clinical Oncology annual meeting in Chicago. The results should be considered preliminary until published... Read more
6 related articles
28d
KTRE Lufkin and Nacogdoches
Many doctors silent on cost of cancer caresupport to facilitate action in response to recognized financial toxicity." Th
KTRE Lufkin and Nacogdoches / Posted 28 days ago
support to facilitate action in response to recognized financial toxicity." The findings were presented recently at the American Society of Clinical Oncology annual meeting in Chicago. The results should be considered preliminary until published... Read more
6 related articles
28d
WALB Albany
Many doctors silent on cost of cancer caresupport to facilitate action in response to recognized financial toxicity." Th
WALB Albany / Posted 28 days ago
support to facilitate action in response to recognized financial toxicity." The findings were presented recently at the American Society of Clinical Oncology annual meeting in Chicago. The results should be considered preliminary until published... Read more
6 related articles
28d
WTVM 9 Columbus
Many doctors silent on cost of cancer caresupport to facilitate action in response to recognized financial toxicity." Th
WTVM 9 Columbus / Posted 28 days ago
support to facilitate action in response to recognized financial toxicity." The findings were presented recently at the American Society of Clinical Oncology annual meeting in Chicago. The results should be considered preliminary until published... Read more
6 related articles
28d
KFVS 12 Cape Girardeau
Many doctors silent on cost of cancer caresupport to facilitate action in response to recognized financial toxicity." Th
KFVS 12 Cape Girardeau / Posted 28 days ago
support to facilitate action in response to recognized financial toxicity." The findings were presented recently at the American Society of Clinical Oncology annual meeting in Chicago. The results should be considered preliminary until published... Read more
6 related articles
28d
WECT 6 Wilmington
Many doctors silent on cost of cancer caresupport to facilitate action in response to recognized financial toxicity." Th
WECT 6 Wilmington / Posted 28 days ago
support to facilitate action in response to recognized financial toxicity." The findings were presented recently at the American Society of Clinical Oncology annual meeting in Chicago. The results should be considered preliminary until published... Read more
6 related articles
28d
The Daily Record
Dr. Vinod M. Varkiat the University of Maryland Medical Center Greenebaum Cancer Center. Varki i
The Daily Record / Posted 28 days ago
at the University of Maryland Medical Center Greenebaum Cancer Center. Varki is currently a member in training with the American Society of Clinical Oncology. He has made multiple lecture presentations on various cancer topics and is a... Read more
29d
News-Medical-Net
Adherence to NCCN Guidelines spares breast cancer patients from unnecessary testsfor patients with early-stage breast cancer are reinforced by other leading org
News-Medical-Net / Posted 29 days ago
for patients with early-stage breast cancer are reinforced by other leading organizations in oncology, including the American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO), and Britain's National Institute... Read more
29d
iol.co.za
Cancer no longer a 'death sentence' as advances in treatment continuein the adjuvant (chemo and targeted treatment after surgery) setting,” Demetrio
iol.co.za / Posted 29 days ago
in the adjuvant (chemo and targeted treatment after surgery) setting,” Demetriou continued. This was discussed at the American Society of Clinical Oncology Conference in Chicago at the beginning of this month, although there is concern that... Read more
29d
CNBC
Trump drug pricing order may be weeks awayaimed at specific molecular targets, regardless of where the disease manifests
CNBC / Posted 29 days ago
aimed at specific molecular targets, regardless of where the disease manifests in the body. This was a major topic at the American Society of Clinical Oncology conference earlier this month: cancer drugs designed not for breast cancer or prostate... Read more
1m
Salon.com
“How long have I got, Doc?” Why many cancer patients don’t have answersif doctors tailor their messages to the needs of the individual, said Dr. Richa
Salon.com / Posted a month ago
if doctors tailor their messages to the needs of the individual, said Dr. Richard Schilsky, chief medical officer of the American Society of Clinical Oncology. When meeting a new patient, he asks two questions: “What do you know about your... Read more
m
Illawarra Mercury
Illawarra patients first in the world to trial new chemo drugWollongong oncologist Professor Philip Clingan. He was among the researchers t
Illawarra Mercury / Posted 1 months ago
Wollongong oncologist Professor Philip Clingan. He was among the researchers to present the exciting findings at the American Society of Clinical Oncology annual conference in Chicago this month. ‘’We are very excited by the results... Read more
22 related articles
m
The Courier
Illawarra patients first in the world to trial new chemo drugWollongong oncologist Professor Philip Clingan. He was among the researchers t
The Courier / Posted 1 months ago
Wollongong oncologist Professor Philip Clingan. He was among the researchers to present the exciting findings at the American Society of Clinical Oncology annual conference in Chicago this month. ‘’We are very excited by the results... Read more
22 related articles
m
Northern Daily Leader
Illawarra patients first in the world to trial new chemo drugWollongong oncologist Professor Philip Clingan. He was among the researchers t
Northern Daily Leader / Posted 1 months ago
Wollongong oncologist Professor Philip Clingan. He was among the researchers to present the exciting findings at the American Society of Clinical Oncology annual conference in Chicago this month. ‘’We are very excited by the results... Read more
22 related articles
m
The Young Witness
Illawarra patients first in the world to trial new chemo drugWollongong oncologist Professor Philip Clingan. He was among the researchers t
The Young Witness / Posted 1 months ago
Wollongong oncologist Professor Philip Clingan. He was among the researchers to present the exciting findings at the American Society of Clinical Oncology annual conference in Chicago this month. ‘’We are very excited by the results... Read more
22 related articles
m
Western Advocate
Illawarra patients first in the world to trial new chemo drugWollongong oncologist Professor Philip Clingan. He was among the researchers t
Western Advocate / Posted 1 months ago
Wollongong oncologist Professor Philip Clingan. He was among the researchers to present the exciting findings at the American Society of Clinical Oncology annual conference in Chicago this month. ‘’We are very excited by the results... Read more
22 related articles
m
Kiama Independent
Illawarra patients first in the world to trial new chemo drugWollongong oncologist Professor Philip Clingan. He was among the researchers t
Kiama Independent / Posted 1 months ago
Wollongong oncologist Professor Philip Clingan. He was among the researchers to present the exciting findings at the American Society of Clinical Oncology annual conference in Chicago this month. ‘’We are very excited by the results... Read more
22 related articles
m
Manning River Times
Illawarra patients first in the world to trial new chemo drugWollongong oncologist Professor Philip Clingan. He was among the researchers t
Manning River Times / Posted 1 months ago
Wollongong oncologist Professor Philip Clingan. He was among the researchers to present the exciting findings at the American Society of Clinical Oncology annual conference in Chicago this month. ‘’We are very excited by the results... Read more
22 related articles
m
Goondiwindi Argus
Illawarra patients first in the world to trial new chemo drugWollongong oncologist Professor Philip Clingan. He was among the researchers t
Goondiwindi Argus / Posted 1 months ago
Wollongong oncologist Professor Philip Clingan. He was among the researchers to present the exciting findings at the American Society of Clinical Oncology annual conference in Chicago this month. ‘’We are very excited by the results... Read more
22 related articles
m
The North West Star
Illawarra patients first in the world to trial new chemo drugWollongong oncologist Professor Philip Clingan. He was among the researchers t
The North West Star / Posted 1 months ago
Wollongong oncologist Professor Philip Clingan. He was among the researchers to present the exciting findings at the American Society of Clinical Oncology annual conference in Chicago this month. ‘’We are very excited by the results... Read more
22 related articles
m
Daily Liberal
Illawarra patients first in the world to trial new chemo drugWollongong oncologist Professor Philip Clingan. He was among the researchers t
Daily Liberal / Posted 1 months ago
Wollongong oncologist Professor Philip Clingan. He was among the researchers to present the exciting findings at the American Society of Clinical Oncology annual conference in Chicago this month. ‘’We are very excited by the results... Read more
22 related articles
m
The Border Mail
Illawarra patients first in the world to trial new chemo drugWollongong oncologist Professor Philip Clingan. He was among the researchers t
The Border Mail / Posted 1 months ago
Wollongong oncologist Professor Philip Clingan. He was among the researchers to present the exciting findings at the American Society of Clinical Oncology annual conference in Chicago this month. ‘’We are very excited by the results... Read more
22 related articles
m
Northern Daily Leader
Illawarra patients first in the world to trial new chemoWollongong oncologist Professor Philip Clingan. He was among the researchers t
Northern Daily Leader / Posted 1 months ago
Wollongong oncologist Professor Philip Clingan. He was among the researchers to present the exciting findings at the American Society of Clinical Oncology annual conference in Chicago this month. ‘’We are very excited by the results... Read more
22 related articles
m
The Young Witness
Illawarra patients first in the world to trial new chemoWollongong oncologist Professor Philip Clingan. He was among the researchers t
The Young Witness / Posted 1 months ago
Wollongong oncologist Professor Philip Clingan. He was among the researchers to present the exciting findings at the American Society of Clinical Oncology annual conference in Chicago this month. ‘’We are very excited by the results... Read more
22 related articles
More

In this news